Johnson Johnson News
Study: Hormone pill slows prostate cancer's growth
A hormone-blocking pill approved last year for some men with advanced prostate cancer now also seems to help a wider group of men who were given it sooner in the course of treating their disease.In a study of nearly 1,100 such men, Johnson & Johnson's Zytiga doubled the time patients lived without their cancer getting worse.The drug also seems to be improving survival, but it will take longer follow-up
Johnson Johnson Galleries
Johnson Johnson Videos
|
|
